Hussman Strategic Advisors, Inc. Innoviva, Inc. Transaction History

Hussman Strategic Advisors, Inc.

$428 Million
Q3 2025

A detailed history of Hussman Strategic Advisors, Inc. transactions in Innoviva, Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 42,000 shares of INVA stock, worth $864,359. This represents 0.18% of its overall portfolio holdings.

Number of Shares

42,000

Previous 210,000 80.0%

Holding current value

$864,359

Previous $4.22 Million 81.84%

% of portfolio

0.18%

Previous 1.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	SELL	$18.17 - $20.92 $3.05 Million - $3.51 Million	-168,000 Reduced 80.0%	42,000 $766,000
Q2 2025 Aug 05, 2025	BUY	$17.1 - $21.8 $718,200 - $915,600	42,000 Added 25.0%	210,000 $4.22 Million
Q4 2024 Feb 03, 2025	BUY	$17.35 - $20.32 $728,700 - $853,440	42,000 Added 33.33%	168,000 $2.91 Million
Q3 2024 Nov 01, 2024	BUY	$16.33 - $20.04 $685,859 - $841,680	42,000 Added 50.0%	126,000 $2.43 Million
Q2 2024 Aug 01, 2024	SELL	$14.4 - $16.4 $1.21 Million - $1.38 Million	-84,000 Reduced 50.0%	84,000 $1.38 Million
Q1 2024 May 01, 2024	BUY	$14.56 - $16.78 $917,280 - $1.06 Million	63,000 Added 60.0%	168,000 $2.56 Million
Q4 2023 Feb 01, 2024	SELL	$12.32 - $16.27 $1.27 Million - $1.68 Million	-103,000 Reduced 49.52%	105,000 $1.68 Million
Q2 2023 Aug 03, 2023	SELL	$11.39 - $13.72 $877,030 - $1.06 Million	-77,000 Reduced 27.02%	208,000 $2.65 Million
Q2 2022 Sep 12, 2022	BUY	$14.32 - $19.88 $1.77 Million - $2.46 Million	123,800 Added 76.8%	285,000 $4.21 Million
Q1 2022 May 04, 2022	BUY	$15.39 - $20.25 $80,028 - $105,300	5,200 Added 3.33%	161,200 $3.12 Million
Q4 2021 Jan 31, 2022	BUY	$15.91 - $18.72 $509,120 - $599,040	32,000 Added 25.81%	156,000 $2.69 Million
Q2 2021 Aug 03, 2021	BUY	$11.45 - $13.96 $430,520 - $524,896	37,600 Added 43.52%	124,000 $1.66 Million
Q1 2021 May 03, 2021	BUY	$11.06 - $12.87 $391,524 - $455,598	35,400 Added 69.41%	86,400 $1.03 Million
Q4 2020 Feb 01, 2021	BUY	$9.33 - $12.48 $475,830 - $636,480	51,000 New	51,000 $632,000
Q2 2019 Jul 31, 2019	SELL	$13.1 - $14.95 $1.64 Million - $1.87 Million	-125,000 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$13.69 - $20.06 $1.03 Million - $1.5 Million	-75,000 Reduced 37.5%	125,000 $1.75 Million
Q4 2018 Feb 01, 2019	BUY	$13.96 - $18.26 $698,000 - $913,000	50,000 Added 33.33%	200,000 $3.49 Million
Q3 2018 Oct 31, 2018	SELL	$13.63 - $15.7 $681,500 - $785,000	-50,000 Reduced 25.0%	150,000 $2.29 Million
Q1 2018 May 01, 2018	BUY	$13.8 - $16.99 $2.76 Million - $3.4 Million	200,000 New	200,000 $3.33 Million

Others Institutions Holding INVA

# of Institutions

287

Shares Held

80M

Call Options Held

10.3K

Put Options Held

161K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.43B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Account

Hussman Strategic Advisors, Inc. Innoviva, Inc. Transaction History